Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Dermatology

Free Subscription 16.06.2025 1 BMC Cancer 3 Br J Dermatol 4 Cancer Lett 1 Cancer Res 3 Clin Exp Dermatol 1 Int J Cancer 5 Int J Dermatol 16 J Dermatol 2 J Invest Dermatol 1 Mycoses 9 PLoS One 5 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Cancer

1. WANG W, Sun Y, Li J, Bai H, et al
   Global, regional, and national burden of breast cancer in young women from 1990 to 2021: findings from the global burden of disease study 2021.
   BMC Cancer. 2025;25:1015.
   PubMed         Abstract available
   
   

   
   Br J Dermatol

2. TAN JY, Marlow L, Phillips C, McPherson T, et al
   Chronic inflammatory skin conditions in adolescents and their impact on intimate relationships - a quantitative and qualitative study.
   Br J Dermatol. 2025 Jun 13:ljaf228. doi: 10.1093.
   PubMed         Abstract available
   
   
3. XIAO H, Ding Y, Shen M, Chen X, et al
   Menopausal Age, Hormone Therapy, and Risk of Psoriasis: A Prospective Cohort Study applying Inverse Probability of Treatment Weighting Analysis.
   Br J Dermatol. 2025 Jun 10:ljaf222. doi: 10.1093.
   PubMed        
   
   
4. SIA T, Li S, Zhong X, Park C, et al
   Acitretin chemoprevention in non-melanoma skin cancer patients with chronic hematopoietic disease: findings from three independent databases.
   Br J Dermatol. 2025 Jun 10:ljaf221. doi: 10.1093.
   PubMed        
   
   

   
   Cancer Lett

5. LIU K, Hoover AR, Sun Y, Valerio TI, et al
   Anti-tumor effects on tumor-infiltrating natural killer cells by localized ablative immunotherapy and immune checkpoint inhibitors: An integrated and comparative study using scRNAseq analysis.
   Cancer Lett. 2025;627:217825.
   PubMed         Abstract available
   
   
6. WU R, Yu S, Bi A, Li Y, et al
   Therapeutic targeting of circTNK2 with nanoparticles restores tamoxifen sensitivity and enhances NK cell-mediated immunity in ER-positive breast cancer.
   Cancer Lett. 2025 May 24:217823. doi: 10.1016/j.canlet.2025.217823.
   PubMed         Abstract available
   
   
7. ZUO WJ, Ma LX, Wang ZH, Cao XC, et al
   Efficacy and safety of inetetamab plus pertuzumab and nab-paclitaxel as neoadjuvant therapy for HER2+ breast cancer: A single-arm multicenter phase II clinical trial.
   Cancer Lett. 2025 May 10:217785. doi: 10.1016/j.canlet.2025.217785.
   PubMed         Abstract available
   
   
8. WANG W, Yang H, Passang T, Li Y, et al
   Targeting the VIP-VPAC Pathway in Melanoma Models Inhibits Tumor Growth and Liver Metastasis.
   Cancer Lett. 2025 Jun 5:217855. doi: 10.1016/j.canlet.2025.217855.
   PubMed         Abstract available
   
   

   
   Cancer Res

9. IBRAHIM M, Illa-Bochaca I, Jour G, Vega-Saenz de Miera E, et al
   NF1 Loss Promotes EGFR Activation and Confers Sensitivity to EGFR Inhibition in NF1 Mutant Melanoma.
   Cancer Res. 2025 Jun 10. doi: 10.1158/0008-5472.CAN-24-3904.
   PubMed         Abstract available
   
   

   
   Clin Exp Dermatol

10. DUFF E, Rynne R, Feighery C, Kearney N, et al
    Skin surgery and cosmetic dermatology.
    Clin Exp Dermatol. 2025 Jun 13:llaf251. doi: 10.1093.
    PubMed        
    
    
11. SHARIFI S, Tan IJ, Jafferany M
    Atopic Dermatitis and Obsessive-Compulsive Disorder: A Systematic Review.
    Clin Exp Dermatol. 2025 Jun 12:llaf259. doi: 10.1093.
    PubMed         Abstract available
    
    
12. BAREI F, Chiei-Gallo A, Narcisi A, Ingurgio RC, et al
    Effectiveness and Safety of Upadacitinib in Patients with Moderate-to-Severe Atopic Dermatitis and Previous Failures of Th2 Biologics: A Propensity Score-Matched Study.
    Clin Exp Dermatol. 2025 Jun 11:llaf253. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Int J Cancer

13. POELCHEN J, Pardo S, Novak D, Sun Q, et al
    Generation and functional analysis of melanoma antigen-specific CD8+ T cells derived from S/MAR vector-transfected human induced pluripotent stem cells.
    Int J Cancer. 2025 Jun 12. doi: 10.1002/ijc.35524.
    PubMed         Abstract available
    
    

    
    Int J Dermatol

14. TRAN TS, Nguyen GH, Guo R
    Sustained Response to PD-1 Inhibitor in an Adolescent With Recurrent Metastasis of Melanoma of Spitzoid Features.
    Int J Dermatol. 2025 Jun 7. doi: 10.1111/ijd.17898.
    PubMed        
    
    
15. GUPTA A, Sharma N, Chaudhry S, Neema S, et al
    Childhood Psoriasis: A Curse or a Boon-Reframing the Narrative to Improve Patient Compliance.
    Int J Dermatol. 2025 Jun 9. doi: 10.1111/ijd.17888.
    PubMed        
    
    
16. CIOBOTARIU I, Lopez-Pardo M, Mas-Lucas MI, Manrique-Silva E, et al
    Survival Prognostic Factors in Patients With Melanoma and Unidentifiable Sentinel Lymph Node: A Case Series of 72 Patients.
    Int J Dermatol. 2025 Jun 9. doi: 10.1111/ijd.17833.
    PubMed        
    
    
17. HIRANO T, Miyake T, Irie H, Kabashima K, et al
    Cutaneous Polyarteritis Nodosa-Like Vasculitis Possibly Induced by Osimertinib.
    Int J Dermatol. 2025 Jun 9. doi: 10.1111/ijd.17890.
    PubMed        
    
    
18. GUPTA AK, Thornbush M, Wang T
    Climate Change, Natural Disasters, and Cutaneous Fungal Infections.
    Int J Dermatol. 2025 Jun 12. doi: 10.1111/ijd.17908.
    PubMed         Abstract available
    
    

    
    J Dermatol

19. KAWAKAMI D, Hagihara E, Hata T, Hasegawa J, et al
    Coconut Anaphylaxis Induced by Occupational Sensitization to Cosmetics via the Skin in a Spa Therapist.
    J Dermatol. 2025 Jun 11. doi: 10.1111/1346-8138.17820.
    PubMed        
    
    
20. KAWASE K, Mizutani Y, Inoue M, Akita H, et al
    A Case of Facial-Type Acquired Dermal Melanocytosis on the Lips Successfully Treated With Laser Therapy.
    J Dermatol. 2025 Jun 11. doi: 10.1111/1346-8138.17800.
    PubMed        
    
    
21. KADONO T, Yamamoto M, Aoyama Y, Nakajima K, et al
    CARD14-Associated Papulosquamous Eruption (CAPE) With Ichthyosis and Malignant Melanoma.
    J Dermatol. 2025 Jun 11. doi: 10.1111/1346-8138.17807.
    PubMed        
    
    
22. YOSHIKAWA S, Kikuchi K, Nozawa K, Nakai Y, et al
    Facial Skin With Conspicuous Enlarged Pores Closely Related to Severity of Facial Acneiform Rash and Therapeutic Effects of EGFR Inhibitors in RAS Wild-Type Metastatic Colorectal Cancer: Ancillary Analysis of FAEISS Study (NCCH1512).
    J Dermatol. 2025 Jun 12. doi: 10.1111/1346-8138.17813.
    PubMed         Abstract available
    
    
23. KIM MC, Gu MJ, Park YS, Kim JG, et al
    Cutaneous Mature Plasmacytoid Dendritic Cell Proliferation in Primary Myelofibrosis: A Case Report.
    J Dermatol. 2025 Jun 12. doi: 10.1111/1346-8138.17803.
    PubMed        
    
    
24. FUKUSHIMA S, Ito T, Asai J, Igaki H, et al
    Japanese Dermatological Association Guidelines: Clinical Questions of Guidelines for Melanoma 2025.
    J Dermatol. 2025 Jun 13. doi: 10.1111/1346-8138.17740.
    PubMed         Abstract available
    
    
25. LU L, Feng J, Zhang S, He H, et al
    Vitiligo associated with type 2 immune inhibitors: FAERS analysis and literature review.
    J Dermatol. 2025;52:1008-1014.
    PubMed         Abstract available
    
    
26. NORIMATSU Y, Hamada T, Ito K, Kimura E, et al
    The importance of pseudohyperchloremia for the diagnosis of bromoderma.
    J Dermatol. 2025;52:1078-1082.
    PubMed         Abstract available
    
    
27. OTSUKA A, Tsunemi Y, Nonaka Y
    Impact of shared decision-making in onychomycosis treatment: A cross-sectional study based on the Illuminating Dialogues and Insights in Onychomycosis Management (IDIOM) survey.
    J Dermatol. 2025;52:1031-1038.
    PubMed         Abstract available
    
    
28. SUEKI H, Sugiyama S, Aoyama Y, Yamamoto T, et al
    Comparing immunopathogenesis of non-human immunodeficiency virus immune reconstitution inflammatory syndrome and immune-related adverse events: A prospective multicenter cohort study.
    J Dermatol. 2025;52:1015-1030.
    PubMed         Abstract available
    
    
29. WANG L, Zhang J, Liu Y, Chen Z, et al
    A novel LSS variant leading to hypotrichosis with pseudoainhum.
    J Dermatol. 2025;52:1103-1106.
    PubMed         Abstract available
    
    
30. AVALLONE G, Maronese CA, Zussino M, Muratori S, et al
    Effectiveness of Dupilumab and Omalizumab in Bullous Pemphigoid: A Nationwide Retrospective Cohort Study.
    J Dermatol. 2025;52:983-1000.
    PubMed         Abstract available
    
    
31. TONE Y, Matsui M, Park A, Otani S, et al
    A Case of Stevens-Johnson Syndrome Induced by Selpercatinib.
    J Dermatol. 2025;52:1066-1069.
    PubMed         Abstract available
    
    
32. LEE BH, Chung KB, Jang H, Jung YW, et al
    HLA-B51 Positivity Correlates With Symptom Completeness From Recurrent Aphthous Stomatitis to Complete Behcet's Disease.
    J Dermatol. 2025;52:1001-1007.
    PubMed         Abstract available
    
    
33. ISEI T, Abe M, Ikegami R, Kato H, et al
    Wound, pressure ulcer, and burn guidelines - 3: Guidelines for the diagnosis and treatment of diabetic ulcers and gangrene, second edition.
    J Dermatol. 2025;52:e391-e429.
    PubMed         Abstract available
    
    
34. MAEKAWA T, Ito T, Idezuki T, Ota M, et al
    Wound, Pressure Ulcer and Burn Guidelines (2023)-5: Guidelines for the Management of Lower Leg Ulcers/Varicose Veins, Third Edition Wound/Pressure Ulcer/Burn Guidelines Drafting Committee (Lower Leg Ulcers/Varicose Veins Group).
    J Dermatol. 2025;52:e481-e528.
    PubMed         Abstract available
    
    

    
    J Invest Dermatol

35. GROLLEAU C, Poisot T, Roux C, Perray L, et al
    Single-cell profiling of lichen planus reveals type I interferon response triggering the interface dermatitis reaction.
    J Invest Dermatol. 2025 Jun 9:S0022-202X(25)00555.
    PubMed         Abstract available
    
    
36. SCHNEIDER MR, Meier M
    Bringing High-Resolution Spatial Order to Sebaceous Glands.
    J Invest Dermatol. 2025 Jun 11:S0022-202X(25)00526.
    PubMed        
    
    

    
    Mycoses

37. ZHANG Y, Xie W, Liu W, Li X, et al
    Epidemiological and Clinical Profile Analysis of Trichophyton mentagrophytes ITS Genotype VII Infected Dermatomycosis: An Emerging Sexually Transmitted Pathogen.
    Mycoses. 2025;68:e70075.
    PubMed         Abstract available
    
    

    
    PLoS One

38. SHAON MA, Ansari F, Mahmud Z, Tamanna S, et al
    Aldo-keto reductase family 1 member C3 (AKR1C3) gene polymorphism (rs12529) is associated with breast cancer in Bangladeshi population: A case-control study and computational investigation.
    PLoS One. 2025;20:e0318079.
    PubMed         Abstract available
    
    
39. LI Y, Zheng C, Cheng S, Chu L, et al
    The relationship between N-terminal pro-brain natriuretic and coronary artery lesions in Kawasaki disease: A meta-analysis.
    PLoS One. 2025;20:e0324552.
    PubMed         Abstract available
    
    
40. ARAFAT HM, Al-Astani TAD, Shafii N, Muhamad R, et al
    Impact of IGFBP-3 A-202C genetic variant on breast cancer susceptibility and serum biomarkers (IGFBP-3 and IGF-1) in Palestinian women.
    PLoS One. 2025;20:e0325289.
    PubMed         Abstract available
    
    
41. FATIMA A, Khan MU, Ibrahim S, Khurram I, et al
    Multiscale computational evaluation of Vitex trifolia phytochemicals as VEGFR2 inhibitors for targeted breast cancer therapy.
    PLoS One. 2025;20:e0325255.
    PubMed         Abstract available
    
    
42. GERAVAND F, Nasli-Esfahani E, Montazer M, Jalalzadeh M, et al
    The association between the quality and quantity of carbohydrate intake and the size, depth, and Wagner grade of diabetic foot ulcers in patients with type 2 diabetes.
    PLoS One. 2025;20:e0323537.
    PubMed         Abstract available
    
    
43. WANG N, Hu G, Xu L, Gong L, et al
    Evaluation of the efficacy, prognosis and safety of dexamethasone in the treatment of different types of non-puerperal mastitis: A retrospective study.
    PLoS One. 2025;20:e0325739.
    PubMed         Abstract available
    
    
44. ZHANG Y, Zhou S, Wang X, Zhou H, et al
    Are metabolic abnormalities the missing link between complete blood count-derived inflammatory markers and diabetic foot? Evidence from a large population study.
    PLoS One. 2025;20:e0326082.
    PubMed         Abstract available
    
    
45. KIM A, Yi C, Ji M, Hwang UJ, et al
    Pectoralis minor length index at 1 month postoperative can predict homolateral neuropathic pain 4 months after mastectomy with lymph node resection.
    PLoS One. 2025;20:e0326119.
    PubMed         Abstract available
    
    
46. GROSSE C, Noack P, Grosse A, Schwarz HK, et al
    Prognostic impact of HER2-low expression in triple-negative breast cancer of high-grade special histological type and no special type.
    PLoS One. 2025;20:e0325715.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

47. ZENG W, Guo H, Liu Q, Wong WH, et al
    Improving polygenic prediction from whole-genome sequencing data by leveraging predicted epigenomic features.
    Proc Natl Acad Sci U S A. 2025;122:e2419202122.
    PubMed         Abstract available
    
    
48. OZAKI MK, Zhang Y, Bartlett AQ, de Wilde E, et al
    Reproductive state controls transcription in the murine liver, with implications for breast cancer liver metastasis.
    Proc Natl Acad Sci U S A. 2025;122:e2420174122.
    PubMed         Abstract available
    
    
49. CROWTHER AJ, Kashem SW, Jewell ME, Le Chang H, et al
    Keratinocyte-TRPV1 sensory neuron interactions in a genetically controllable mouse model of chronic neuropathic itch.
    Proc Natl Acad Sci U S A. 2025;122:e2411724122.
    PubMed         Abstract available
    
    
50. DING Q, Liu J, Wang Y, Kim J, et al
    Dual-laser "808 and 1,064 nm" strategy that circumvents the Achilles' heel of photothermal therapy.
    Proc Natl Acad Sci U S A. 2025;122:e2503574122.
    PubMed         Abstract available
    
    
51. ZERILLO L, Zotti T, Tutela A, Madera JR, et al
    The CARD14sh-BCL10-MALT1 complex regulates MAVS-mediated antiviral response in keratinocytes.
    Proc Natl Acad Sci U S A. 2025;122:e2500711122.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Dermatology is free of charge.